ID 5OIRA STANDARD; PRT; 269 AA. DT CONVERTED FROM PDB (SEQRES) 5OIR DE Enoyl-[acyl-carrier-protein] reductase [NADH] OS Mycobacterium tuberculosis CC EXPDTA X-RAY DIFFRACTION CC RESOLU 1.970 CC R-Factor 0.154 FT #HET 14 14 GLY A 1 301 NAD A B 6 FT #HET 15 15 ILE A 1 301 NAD A B 3 FT #HET 16 16 ILE A 1 301 NAD A A 9 FT #HET 19 19 SER A 7 307 SO4 A A 10 FT #HET 20 20 SER A 1 301 NAD A A 5 FT #HET 21 21 ILE A 1 301 NAD A A 8 FT #HET 24 24 HIS A 7 307 SO4 A S 4 FT #HET 41 41 PHE A 1 301 NAD A S 25 FT #HET 63 63 LEU A 1 301 NAD A B 2 FT #HET 64 64 ASP A 1 301 NAD A A 6 FT #HET 65 65 VAL A 1 301 NAD A A 11 FT #HET 94 94 SER A 1 301 NAD A A 10 FT #HET 95 95 ILE A 1 301 NAD A A 12 FT #HET 96 96 GLY A 1 301 NAD A B 8 FT #HET 96 96 GLY A 2 302 9W8 A B 6 FT #HET 97 97 PHE A 2 302 9W8 A A 12 FT #HET 97 97 PHE A 6 306 ETX A S 3 FT #HET 98 98 MET A 2 302 9W8 A B 5 FT #HET 99 99 PRO A 6 306 ETX A A 6 FT #HET 100 100 GLN A 6 306 ETX A A 3 FT #HET 103 103 MET A 2 302 9W8 A S 5 FT #HET 103 103 MET A 3 303 ETX A S 1 FT #HET 104 104 GLY A 3 303 ETX A B 1 FT #HET 118 118 LYS A 6 306 ETX A S 4 FT #HET 122 122 ILE A 1 301 NAD A S 4 FT #HET 132 132 LYS A 4 304 ETX A S 7 FT #HET 147 147 MET A 1 301 NAD A A 6 FT #HET 148 148 ASP A 1 301 NAD A B 3 FT #HET 149 149 PHE A 1 301 NAD A S 3 FT #HET 149 149 PHE A 2 302 9W8 A S 5 FT #HET 149 149 PHE A 3 303 ETX A S 1 FT #HET 152 152 SER A 5 305 ETX A B 1 FT #HET 155 155 MET A 3 303 ETX A S 1 FT #HET 157 157 ALA A 3 303 ETX A A 3 FT #HET 158 158 TYR A 2 302 9W8 A S 9 FT #HET 158 158 TYR A 3 303 ETX A S 5 FT #HET 161 161 MET A 1 301 NAD A S 1 FT #HET 161 161 MET A 2 302 9W8 A S 1 FT #HET 165 165 LYS A 1 301 NAD A S 6 FT #HET 165 165 LYS A 2 302 9W8 A S 1 FT #HET 191 191 ALA A 1 301 NAD A A 2 FT #HET 192 192 GLY A 1 301 NAD A B 1 FT #HET 193 193 PRO A 1 301 NAD A B 2 FT #HET 194 194 ILE A 1 301 NAD A B 6 FT #HET 194 194 ILE A 7 307 SO4 A S 4 FT #HET 195 195 ARG A 7 307 SO4 A B 2 FT #HET 196 196 THR A 1 301 NAD A S 2 FT #HET 196 196 THR A 7 307 SO4 A B 2 FT #HET 199 199 MET A 2 302 9W8 A S 5 FT #HET 202 202 ILE A 3 303 ETX A S 2 FT #HET 207 207 LEU A 3 303 ETX A S 1 FT #HET 215 215 ILE A 3 303 ETX A S 5 FT #HET 218 218 LEU A 3 303 ETX A S 1 FT #HET 233 233 LYS A 7 307 SO4 A B 2 FT #HET 235 235 ALA A 7 307 SO4 A A 2 FT DISORDER 1 2 CC SEQUENCE 267 AA (ATOM); CC GLLDGKRILV SGIITDSSIA FHIARVAQEQ GAQLVLTGFD RLRLIQRITD RLPAKAPLLE CC LDVQNEEHLA SLAGRVTEAI GAGNKLDGVV HSIGFMPQTG MGINPFFDAP YADVSKGIHI CC SAYSYASMAK ALLPIMNPGG SIVGMDFDPS RAMPAYNWMT VAKSALESVN RFVAREAGKY CC GVRSNLVAAG PIRTLAMSAI VGGALGEEAG AQIQLLEEGW DQRAPIGWNM KDATPVAKTV CC CALLSDWLPA TTGDIIYADG GAHTQLL CC !---- CC ALIGNMENT OF SEQRES AND ATOMRES CC SEQRES MAGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRI CC ATOM --GLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRI CC ************************************************ CC SEQRES TDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQ CC ATOM TDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQ CC ************************************************** CC SEQRES TGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFD CC ATOM TGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFD CC ************************************************** CC SEQRES PSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMS CC ATOM PSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMS CC ************************************************** CC SEQRES AIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWL CC ATOM AIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWL CC ************************************************** CC SEQRES PATTGDIIYADGGAHTQLL CC ATOM PATTGDIIYADGGAHTQLL CC ******************* SQ SEQUENCE 269 AA; MW; CN; MAGLLDGKRI LVSGIITDSS IAFHIARVAQ EQGAQLVLTG FDRLRLIQRI TDRLPAKAPL LELDVQNEEH LASLAGRVTE AIGAGNKLDG VVHSIGFMPQ TGMGINPFFD APYADVSKGI HISAYSYASM AKALLPIMNP GGSIVGMDFD PSRAMPAYNW MTVAKSALES VNRFVAREAG KYGVRSNLVA AGPIRTLAMS AIVGGALGEE AGAQIQLLEE GWDQRAPIGW NMKDATPVAK TVCALLSDWL PATTGDIIYA DGGAHTQLL //